Cirrhosis of the liver
267 results
1 - 100
Cirrhosis of the liver 
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease New- Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease New
- Bezafibrate for primary biliary cirrhosis: Cochrane systematic review
- Colchicine for primary biliary cirrhosis Edited (no change to conclusions)
- Ursodeoxycholic acid for primary biliary cirrhosis New search for studies and content updated (no change to conclusions)
- Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis: Cochrane systematic review
- Methotrexate for primary biliary cirrhosis New search for studies and content updated (no change to conclusions)
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- D-penicillamine for primary biliary cirrhosis: Cochrane systematic review
- Colchicine for primary biliary cirrhosis
- D-penicillamine for primary biliary cirrhosis
Useful clinical indicators to diagnose cirrhosis- Hormone replacement for osteoporosis in women with primary biliary cirrhosis: Cochrane systematic review
- Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis New
- Glucocorticosteroids for primary biliary cirrhosis: Cochrane systematic review
- Primary sclerosing cholangitis
- Bisphosphonates for osteoporosis in primary biliary cirrhosis: Cochrane systematic review
- Cyclosporin A for primary biliary cirrhosis: Cochrane systematic review
- Methotrexate for primary biliary cirrhosis
- Assessing a patient with an abnormal liver function test result
- Treatment of hepatocellular carcinoma associated with cirrhosis
- Antioxidant supplements for liver diseases: Cochrane systematic review
- Cyclosporin A for primary biliary cirrhosis
- Glucocorticosteroids for primary biliary cirrhosis
- Somatostatin analogues for acute bleeding oesophageal varices Stable (no update expected for reasons given in 'What's new')
- Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): Cochrane systematic review
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis New
- Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta‐analysis New
- Autoimmune hepatitis
- Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis: Cochrane systematic review
- Platelet count/spleen diameter ratio in predicting the presence of oesophageal varices in patients with cirrhosis
- Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis New
- Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome: Cochrane systematic review
- Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis: Cochrane systematic review
- Curable causes of memory-related symptoms and diseases
- Bile acids for liver‐transplanted patients New search for studies and content updated (no change to conclusions)
- Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis Edited (no change to conclusions)
- Chlorambucil for patients with primary biliary cirrhosis: Cochrane systematic review
- Glucocorticosteroids for primary sclerosing cholangitis: Cochrane systematic review
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis New
- Organ transplant recipient in primary health care
- Skin colour changes and pigmentary disorders
- Ultrasonographic examinations
- Anabolic-androgenic steroids for alcoholic liver disease: Cochrane systematic review
- Primary biliary cholangitis
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
- Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
- Azathioprine for primary biliary cirrhosis: Cochrane systematic review
- Branched‐chain amino acids for people with hepatic encephalopathy Edited (no change to conclusions)
- Clinical factors predict death in patients with cirrhosis + UGI bleeding
- Hyponatraemia
- Terlipressin for acute esophageal variceal hemorrhage Edited (no change to conclusions)
- Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: Cochrane systematic review
- The icteric patient
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices New
- Antioxidant supplements for liver diseases
- Haemochromatosis
- Vitamin E improves histology of NASH, patient-oriented benefit unknown
- Unintentional weight loss in adults